Optimal timing of staged percutaneous coronary intervention after subintimal tracking and re‐entry: Rationale and design of the subintimal tracking and re‐entry with deferred stenting study

Abstract

AbstractBackgroundTen to fifteen percent of chronic total occlusion (CTO) percutaneous coronary interventions (PCIs) are unsuccessful in contemporary practice. Subintimal tracking and re‐entry (STAR) (one form of “investment procedure”) with staged reattempt and stenting may further increase the ultimate success and safety of CTO as a bailout strategy. The optimal timing for staged stenting after STAR is unknown.Methods and ResultsWe designed a six‐center, prospective randomized trial with a planned enrollment of 150 patients where STAR is utilized in case of impending failure. The primary aim is to evaluate the optimal timing of the staged PCI after STAR by randomizing the timing to earlier (5–7 weeks) versus later (12–14 weeks) staged PCI. The primary endpoint of the study is the technical success rate of the staged procedure. The secondary endpoints include: (1) the rate of thrombolysis in myocardial infarction 3 flow at the start of staged intervention, (2) rate of partial technical and procedural success of the staged procedure, (3) rate of in‐hospital and 12‐month major cardiac and cerebrovascular adverse events, and (4) change in patient‐reported quality at 30 days, 6 months, and 12 months assessed by Seattle Angina Questionnaire.ConclusionThis study will ascertain the optimal timing of staged stenting after bail‐out STAR approach in contemporary CTO PCI (ClinicalTrials.gov NCT05089864).